Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigehisa Kitano

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2017
[Combination Therapy of Immune Checkpoint Inhibitors]Shigehisa Kitano
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2017
Development of immune checkpoint inhibitorsShigehisa Kitano
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 13, 2017
[III. Recent Clinical Development of Cancer Immunotherapy and Speculation for Bone and Soft Tissue Tumors]Shigehisa Kitano
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 30, 2023
[Development of Novel Gene-Modified T-Cell Therapies(CAR-T, TCR-T)]Shigehisa Kitano
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 15, 2018
Development of immune checkpoint inhibitor in colorectal cancerShigehisa Kitano
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 11, 2019
[Ⅲ.Cross-Organ Developmental Status and Challenges of Immune Checkpoint Inhibitors]Shigehisa Kitano
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
Anti-PD-1 antibody and anti-PD-Li antibody -from basic and clinic-Shigehisa Kitano
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 6, 2019
[Clinical Significance of Ipilimumab and the Combination Therapy as Immune Checkpoint Inhibitor]Yusuke Muto, Shigehisa Kitano
International Journal of Urology : Official Journal of the Japanese Urological Association|February 3, 2019
Immunotherapy for genitourinary tumorsTakayuki Nakayama, Shigehisa Kitano
Frontiers in Oncology|August 4, 2018
Biomarkers for Immune Checkpoint Inhibitors in MelanomaShigehisa Kitano, Takayuki Nakayama, Makiko Yamashita
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2017
[Combination Therapy of Immune Checkpoint Inhibitors]Shigehisa Kitano
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2017
Development of immune checkpoint inhibitorsShigehisa Kitano
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 13, 2017
[III. Recent Clinical Development of Cancer Immunotherapy and Speculation for Bone and Soft Tissue Tumors]Shigehisa Kitano
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 30, 2023
[Development of Novel Gene-Modified T-Cell Therapies(CAR-T, TCR-T)]Shigehisa Kitano
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 15, 2018
Development of immune checkpoint inhibitor in colorectal cancerShigehisa Kitano
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 11, 2019
[Ⅲ.Cross-Organ Developmental Status and Challenges of Immune Checkpoint Inhibitors]Shigehisa Kitano
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
Anti-PD-1 antibody and anti-PD-Li antibody -from basic and clinic-Shigehisa Kitano
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 6, 2019
[Clinical Significance of Ipilimumab and the Combination Therapy as Immune Checkpoint Inhibitor]Yusuke Muto, Shigehisa Kitano
International Journal of Urology : Official Journal of the Japanese Urological Association|February 3, 2019
Immunotherapy for genitourinary tumorsTakayuki Nakayama, Shigehisa Kitano
Frontiers in Oncology|August 4, 2018
Biomarkers for Immune Checkpoint Inhibitors in MelanomaShigehisa Kitano, Takayuki Nakayama, Makiko Yamashita
Pageof 15